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Abstract
Background: The shortage of human resources for health, and in particular physicians, is one of the major barriers to
achieve universal access to HIV care and treatment. In September 2005, a pilot program of nurse-centered antiretroviral
treatment (ART) prescription was launched in three rural primary health centers in Rwanda. We retrospectively evaluated
the feasibility and effectiveness of this task-shifting model using descriptive data.
Methods and Findings: Medical records of 1,076 patients enrolled in HIV care and treatment services from September 2005
to March 2008 were reviewed to assess: (i) compliance with national guidelines for ART eligibility and prescription, and
patient monitoring and (ii) key outcomes, such as retention, body weight, and CD4 cell count change at 6, 12, 18, and
24 mo after ART initiation. Of these, no ineligible patients were started on ART and only one patient received an
inappropriate ART prescription. Of the 435 patients who initiated ART, the vast majority had adherence and side effects
assessed at each clinic visit (89% and 84%, respectively). By March 2008, 390 (90%) patients were alive on ART, 29 (7%) had
died, one (,1%) was lost to follow-up, and none had stopped treatment. Patient retention was about 92% by 12 mo and
91% by 24 mo. Depending on initial stage of disease, mean CD4 cell count increased between 97 and 128 cells/ml in the first
6 mo after treatment initiation and between 79 and 129 cells/ml from 6 to 24 mo of treatment. Mean weight increased
significantly in the first 6 mo, between 1.8 and 4.3 kg, with no significant increases from 6 to 24 mo.
Conclusions: Patient outcomes in our pilot program compared favorably with other ART cohorts in sub-Saharan Africa and
with those from a recent evaluation of the national ART program in Rwanda. These findings suggest that nurses can
effectively and safely prescribe ART when given adequate training, mentoring, and support.
Please see later in the article for the Editors’ Summary.
Citation: Shumbusho F, van Griensven J, Lowrance D, Turate I, Weaver MA, et al. (2009) Task Shifting for Scale-up of HIV Care: Evaluation of Nurse-Centered
Antiretroviral Treatment at Rural Health Centers in Rwanda. PLoS Med 6(10): e1000163. doi:10.1371/journal.pmed.1000163
Academic Editor: Frank Feeley, Boston University, United States of America
Received February 13, 2009; Accepted September 3, 2009; Published October 13, 2009
Copyright:  2009 Shumbusho et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Costs for the study were supported under USAID grant no. 696-A-00-06-00097-00 to Family Health International. The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Abbreviations: 3TC, lamivudine; ART, antiretroviral treatment; AZT, zidovudine; d4T, stavudine; EFV, efavirenz; FHI, Family Health International; IQR, interquartile
range; LTFU, lost to follow-up; MD, medical doctor; NVP, nevirapine; PHC, primary health center.
* E-mail: Fabiennes@fhirw.org
PLoS Medicine | www.plosmedicine.org 1 October 2009 | Volume 6 | Issue 10 | e1000163Background
Although significant progress has been made in the provision of
antiretroviral treatment (ART) in sub-Saharan Africa, only 30% of
patients eligible for ART were receiving treatment by the end of
2007 [1]. In many countries, the shortage of human resources for
health is one of the major barriers to achieve universal access to
HIV care and treatment [2]. In particular, reliance on physician-
and hospital-centered care hampers the ability to scale-up ART. As
a result, the World Health Organization (WHO) has recommended
task shifting—the process of delegation of tasks to health workers
with lower qualifications—as a necessary and critical dimension of
decentralized AIDS care in Africa [3,4]. Whereas task shifting,
including that for HIV care delivery, is well-studied and established
inrichcountries,onlylimited publisheddataexistfromHIVsettings
in sub-Saharan Africa [5]. As such, the level of training and support
needed to implement task-shifting models, and the quality of care
provided within these settings, remains largely unknown. Conse-
quently, national ART programs in resource-limited countries have
been slow to adopt this approach.
With a population of around 9 million inhabitants, Rwanda has an
overall HIV prevalence of 3% and more than 7% in urban areas [6].
The national ART program, launched in 2003, was first established at
the district level and was subsequently decentralized to primary health
centers (PHCs); by the end of 2007, 171 (39%) of the 434 health
facilities provided ART services, most of these being PHCs [7]. The
Government of Rwanda currently does not allow ART prescription by
nurses. However, with one physician per 50,000 inhabitants and one
nurse per 3,900 habitants, Rwanda faces a severe physician shortage
but is relatively better resourced with nurses [8]. In addition, 80%–
90% of the population is rural-based and relies primarily on health
services at PHCs staffed by nurses. Even at the PHC level, the bulk of
HIV care is medical doctor (MD)-centered and provided by visiting
physicians, typically based at district hospitals. With the permission of
the Rwanda Ministry of Health (MOH), in 2005 Family Health
International (FHI) developed a task-shifting model to assess the
feasibility and effectiveness of nurse-initiated AIDS treatment as a basis
for further national policy development. In three rural PHCs, nurses
were trained to prescribe first-line ART regimens for treatment-naı ¨ve
adult patients with ongoing physician supervision and mentoring.
In this article, we report evaluation results of the pilot
intervention. Specifically, we present descriptive data extracted
from patient records to assess (i) nurse performance vis-a `-vis
compliance with national clinical guidelines for HIV care and
treatment, and (ii) key patient outcomes, including retention, body
weight, and CD4 cell count change after treatment initiation. The
initiative was funded as an intervention rather than as a research
project, and limited resources precluded using a comparative study
design. However, we hope that these data will help to inform
future efforts to either scale-up the current initiative in Rwanda or
plan similar initiatives elsewhere.
Methods
ART Patient Management
The intervention was designed to enable nurses at PHCs within
existing ART services to prescribe first-line ART regimens, ensure
the management of ART-naı ¨ve adult cases, and organize referral
of complex cases. Pediatric patients, ART non-naı ¨ve adults, and
patients with associated medical conditions (e.g., tuberculosis), or
severe baseline laboratory abnormalities, were considered complex
and were excluded from nurse-initiated treatment. These patients
were referred to the supervising physician for ART initiation,
follow-up, or both. Table 1 summarizes the differences between
this nurse-centered and the traditional physician-centered models
of AIDS care.
Table 1. Role of physicians and nurses in the traditional MD-centered HIV/ART care program and the nurse-centered pilot project.
Phase of Care Tasks MD-Centered Nurse-Centered
Role MD Role Nurse Role MD Role Nurse
Pre-ART care Initial physical exam/staging X— — X
Ordering CD4 count XX — X
Assessment of ART eligibility X— — X
Follow-up of noneligible patients X— — X
Cotrimoxazole refill —X —X
a
Complex medical cases
b X— X—
ART care Ordering lab tests XX — X
Interpretation of lab tests X— — X
ART initiation and FU of noncomplex cases X— — X
ART initiation and FU of complex cases
b X— X—
ART refill —X —X
a
Register keeping/reporting —X —X
Filing of results/medical records —X —X
a
Training/mentoring —— X —
Supervision —— X —
aThese tasks were taken over from the prescribing nurse by other staff (nurses, social workers).
bComplex cases included those with advanced HIV disease, severe/persistent opportunistic infections, severe ART side effects, suspicion of ART failure, severe or
recurrent nonadherence to ART, pediatric (,15 y), and ART-experienced patients.
doi:10.1371/journal.pmed.1000163.t001
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guidelines, which are based on WHO clinical and immunological
eligibility criteria: WHO clinical stage IV without consideration of
CD4 count; CD4 count #200/ml with previous guidelines and
#350/ml with revised July 2007 guidelines. A majority of patients
received a generic, fixed-dose combination of stavudine (d4T),
lamivudine (3TC), and nevirapine (NVP). From the beginning of
2008, zidovudine (AZT) replaced d4T in the preferred first-line
regimen in the national guidelines. Nurses in this pilot program
were instructed about contraindications to specific ARV medica-
tions per national preservice training. For those with baseline
neuropathy, d4T was to be replaced with AZT, except for patients
with concurrent anemia (hemoglobin ,9 g/dl). NVP was replaced
by efavirenz (EFV) for tuberculosis patients or those with grade
III/IV liver toxicity at baseline, after excluding pregnancy.
ART adherence was evaluated at each patient visit by self-
report and pill counts. Side effects were evaluated at each follow-
up visit, and treatment changes were made for grade 3 and 4
events [9]. For those cases, changes of treatment were made by the
visiting MD. Prior to a change in treatment, interruptions to
treatment might have been indicated for various reasons, such as
an allergic reaction; if such cases occurred when no MD was on
hand and if no transfer to the hospital was organized, the nurse
made the interruption. Liver function tests were performed at
baseline, 2, 4, and 8 wk, and thereafter every 6 mo and on clinical
grounds. A full blood count (FBC) was done at baseline, 12 wk,
and thereafter every 6 mo and on clinical grounds. For patients on
AZT, an additional FBC control was done at 4 and 8 wk. From
the beginning of 2007, laboratory monitoring was simplified
according to the national guidelines, with measurement of serum
glucose, amylase, transaminases, and creatinine for cases present-
ing indications only but not for routine exams, and keeping
hemogram as an initial mandatory exam and on a regular basis in
case of AZT. CD4 cell count measurements, checked every 6 mo
while on ART, were performed at the laboratory of the District
Hospital using FACSCount technology (Becton-Dickenson).
Study Setting and Description of the Intervention
In consultation with the MOH, FHI provided technical
assistance to four rural PHCs to implement the intervention.
Selection criteria included: (i) comprehensive services for HIV care
in place (counselling and testing, prevention of mother-to-child
transmission, and AIDS patient care and treatment); (ii) supervi-
sion and support by a district hospital that was already providing
ART to patients; and (iii) a nurse on staff who had at least 2 y
experience providing clinical care for non-HIV pathologies. Other
factors for PHC selection were geographic diversity, infrastructure,
and overall staffing patterns that were considered standard in
Rwanda. Of the four PHCs initially selected, one was later
excluded because of staffing changes that precluded nurse-initiated
ART. Data from this PHC are not included in the current
analysis. Characteristics of the three remaining PHCs are similar
to other rural sites in Rwanda, with catchment area populations of
15,000 to 28,000 inhabitants, 45 to 117 km from the capital
Kigali, none connected to the electric grid, and ten to 17 staff, with
some of those being additional personnel provided for this
intervention. Estimated HIV prevalence within the two districts
where the three PHCs are located was 5.3% (Muhanga) and 4.6%
(Nyanza), based on 2007 antenatal consultation (ANC) sentinel
surveillance.
One nurse at each PHC was trained by a physician from FHI
to: (i) perform physical exams of HIV patients and to order and
interpret blood tests during patient enrollment and follow-up; (ii)
prescribe ART to noncomplex adult cases; and (iii) refer complex
cases, including children, to the physician (MD) (Table 1). Selected
nurses first received formal training in national treatment
guidelines, followed by a 5-d practicum training at an established
ART site and 5–10 d ‘‘bedside’’ training (see Table 2). ‘‘Bedside’’
training involved nurse-consultation of all HIV-positive patients
(ART-eligible and noneligible) under the observation of the
physician. After a minimum of 50 physician-observed consulta-
tions had been completed with ART-eligible patients, nurses were
allowed to consult patients independently but were provided
ongoing physician support from a distance with weekly supervision
and mentoring at the PHC treatment site. In each facility, an
additional nurse received the training, in order to ensure
replacement of staff in the ART service in case of need.
While the nurses participating in the pilot intervention were
specifically assigned to attend to HIV patients, they continued to play
ar o l ei no v e r a l lp a t i e n tc a r ea c c o r d i n gt oe a c hf a c i l i t y ’ so r g a n i z a t i o n
of clinic staff. The nurses did not receive salary increases or other
incentives for their new role under this task-shifting initiative.
Table 2. Training and supervision activities within the pilot project.
Activity Description
Training
Theoretical training 2 wk-training on HIV care and ART (as part of national training program organized for physicians, nurses, and social workers)
Practical training 5 d-training in established ART site (as part of national training program): introduction to nursing aspects of ART including
pre-ART patient preparation and adherence support, dispensing ARVs, organizational and reporting activities
On-the-job training ‘‘Bed-side teaching’’- training with the FHI MD at the pilot site (5–10 d in total): joint consultation with emphasis on ARVs,
monitoring (side effects, adherence, laboratory); clinical skills; OI diagnosis and management. Supervised prescription of ART
(once weekly visits); minimum 50 cases initiated and monitored under supervision. Supervision tool for evaluation. Telephonic
consult/advice by MD at all times. Formal evaluation prior to prescribing ART independently.
Supervision
By District MD
a Weekly visits to confirm ART prescriptions, review medical/complex cases and supervise monitoring activities; ongoing
training and mentoring
By FHI MD Supervision of activities of ART team (nurse and district MD) on: medical aspects (case discussions, patient file review);
completeness of patient files and program registers. Monthly visits at start, later every 3 mo. Ongoing training and mentoring.
Guided by supervision tool.
aGiven the shortage of MDs at one district hospital, the FHI MD temporarily functioned as the district MD at two intervention sites.
OI, opportunistic infections.
doi:10.1371/journal.pmed.1000163.t002
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in Table 1, during these visits, MDs ensured the management of
complex cases, including cases of advanced HIV disease, severe
opportunistic infections, severe ART side effects, suspicion of ART
failure, severe or recurrent nonadherence to ART, and ART-
experienced patients. MDs also verified the prescriptions made by
nurses, and provided guidance and advice on specific cases,
general aspects of care, and the organization of services (Table 2).
To facilitate nurse-initiated ART prescription and patient
management, the national patient record, designed for use by
MDs, was adapted for use by nurses following WHO task-shifting
recommendations [10]. We developed check-lists to guide nurses
to collect and assess essential data elements including: sociode-
mographic characteristics of the patient; baseline clinical assess-
ment and WHO staging; contraindications for nurse-ART
prescription; and screening for side effects and nonadherence
during follow-up appointments. To clarify and reinforce nurse
responsibilities and indications for physician referral, we developed
an algorithm for patient management. Finally, we used standard-
ized evaluation forms to guide routine MD supervision.
Data Collection and Statistical Analysis
Patient records were examined retrospectively to assess nurse
performance in implementing national treatment guidelines and
patient outcomes under nurse care. All adult patients who were
enrolled into HIV care or who started ART after the pilot start-up
in September 2005 and up to the time of data abstraction in
March 2008 were included in the assessment. Patients who were
transferred from other sites while on ART or who started
prophylactic ART for prevention of mother-to-children transmis-
sion were excluded from assessment.
Completeness of patient data was assessed at baseline for the
following parameters: WHO clinical stage, functional status [10],
weight, review of systems, and physical exam; baseline CD4 cell
count and laboratory tests; screening for tuberculosis and
reproductive health issues. ART eligibility was ascertained and
compared with the nurse’s decision. For patients determined
eligible, the presence of contraindications for nurse ART
prescription was assessed. For patients started on ART, the
correctness of the ART prescription was verified as per the
national guideline (combination of drugs, prescription despite
contraindication). The completeness of follow-up was assessed for
weight and CD4 cell count measurements, adherence assessments,
and screening for side effects. To assess the nurse’s responsiveness
towards persistent side effects, defined as those reported at three or
more consecutive follow-up visits, we evaluated whether the side
effect management was documented and whether the patient had
been appropriately referred to the physician.
The key patient outcomes assessed were patient retention by the
time of data abstraction, CD4 cell count, and weight evolution
after ART initiation. Clinical status was defined as: alive and on
ART, lost to follow-up (LTFU; LTFU was defined as ‘‘not
showing or absent at the health center for more than 3 mo since
the last visit, without alternative explanation’’), transferred to
another site, or died. No data on the cause of death were collected.
Since varying definitions of retention can be found in the
literature, we used the two most commonly reported definitions.
Under the first definition, patients are considered to be ‘‘retained
in the system’’ if they are known to be alive and on ART at the
time of assessment, including transfers to other ART sites [11].
Under the second definition, patients who transferred to another
ART site are considered to be nonretained (‘‘retention at the
facility level’’). The proportion of patients requiring toxicity-
related drug substitution and regimen switch for treatment failure
was reported as well.
Data were collected from the three sites by a team consisting of
three trained data entry persons and one supervisor. Data were
abstracted from the patient files and entered into an Access-
database using a data-entry mask in Epi Info (version 3.3.2, US
Centers for Disease Control).
For mortality and retention, we estimated cumulative event
probabilities through 24 mo after ART initiation using Kaplan-
Meier methods. For mortality, estimated curves were stratified by
baseline WHO stage and CD4 cell count and we used the log-rank
test for comparing groups.
For describing CD4 cell count and weight evolution over time
following ART initiation, we applied general linear mixed models
using restricted maximum likelihood. To avoid a false perception
of improving outcomes caused by sicker patients dying early, we
excluded from the analyses of CD4 and weight all patients who
died, were lost, or were transferred prior to their 6-mo assessment.
Models included fixed effects for baseline characteristics, including
health center, WHO stage, age, gender, and ART regimen.
Additionally, the CD4 model included a term for baseline weight
and the weight model included a term for baseline CD4. We also
included as fixed effects polynomials of time and interactions
between WHO stage and time. For CD4, a quadratic model fit
adequately (based on a likelihood ratio test), while for weight cubic
terms were required. Random effects included patient-specific
intercept, slope, and quadratic term increments. Change over time
was assessed using appropriately specified contrasts. Model and
test results are presented for the purposes of describing our study
population only and are not intended for making inferences to any
larger population. All analyses were performed using SAS, Version
9.1 (SAS Institute).
Ethical Considerations
This study analyzed routine data of the HIV care program. The
Rwandan National Ethics Committee (RNEC, Kigali, Rwanda)
gave exemption from formal ethical review.
Results
Between September 2005 and March 2008, 1,076 adult patients
were enrolled into HIV care or started lifelong ART within the
pilot program. Of these, 710 (66%) were women and the median
age was 38 y (interquartile range [IQR] 31–45) (Table 3). Most
were WHO clinical stage I (53%) or WHO clinical stage II (28%)
at the time of enrollment. Overall, 435 patients (40%) were started
on ART, with a median baseline CD4 cell count of 184 cells/ml
(IQR 116–231). Most patients who initiated ART were either
WHO clinical stage II (39%) or III (35%); only 2% were stage IV.
The median follow-up time on ART at the time of assessment was
8.3 mo (IQR 2.6–15.9).
Of the 622 patients who were determined to be ineligible for
ART, none were started on treatment. We identified 451 patients
who were eligible for ART, of which 435 (96%) started treatment.
The other 16 (4%) did not start treatment for various reasons: six
did not return for ART initiation, five were receiving pre-ART
counselling at the time of data collection, one was transferred after
the initial assessment, and two died prior to ART initiation. For
two cases, we did not find a clear explanation for the delay in ART
initiation. The majority of patients were reported to be screened
for tuberculosis, had reproductive health issues assessed, were
clinically examined, and were assessed for contraindications for
nurse-initiated treatment (Table 4). For those who initiated ART,
the median time between the HIV test and ART initiation was
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CD4 sample collection and ART initiation.
The most commonly prescribed regimens were d4T+3TC+NVP
(69%) and AZT+3TC+NVP (26%); d4T+3TC+EFV (4%) and
AZT+3TC+EFV (1%) were used less frequently. All drug prescrip-
tions were consistent with the national guidelines, except that one
patient was given EFV without prior exclusion of pregnancy. In no
observed cases did nurses initiate ART in the presence of a
contraindication. Twenty-three (5.3%) patients changed their initial
ART regimen and, of these, the majority were single-drug
substitutions due to toxicity. Only three patients were started on
second-line ART for treatment failure by the visiting MDs. During
follow-up, ART adherence, based on self-report, was assessed at
every visit for 89% of the patients, and screening for side effects was
performed regularly for 83%. For the seven patients documented to
have persistent side effects, management was clearly documented for
five (71%). CD4 count results and weight measurements while on
treatment were available for the majority of patients (Table 4).
By the time of assessment, 390 (90%) of the 435 patients initiating
ART were alive and on ART within the pilot PHCs. Twenty-nine
(7%) patients had died, one (,1%) was LFTU, and 15 (3%) had
been transferred to another ART site. The median time on
treatment for those who died was 1.9 mo (IQR 0.7–3.7); 62% of
deaths occurred within 3 mo after treatment initiation, and 86%
within 6 mo. As seen in Figure 1, mortality was strongly associated
with advanced WHO disease stage and low baseline CD4 count.
Estimated retention in the system was 93% at 6 mo, 92% at 12 mo,
and 91% at 18 and 24 mo (Figure 2). Estimated retention at the facility
level decreased to 80% by 24 mo. The model-estimated mean CD4
cell count and weight changes while on treatment, stratified by WHO
stage, are summarized in Table 5. Depending on initial WHO stage,
increases in mean CD4 cell count ranged from 97 to 128 cells/mlf r o m
pre-ART to 6 mo following treatment initiation and from 79 to 129
cells/ml from 6 to 24 mo after treatment initiation. Similarly, mean
weight significantly increased between 1.8 and 4.3 kg in the first 6 mo
following treatment initiation; mean weight also increased between 0.5
and 1.7 kg in the period between 6 and 24 mo, however these
increases were not significantly different from zero.
Discussion
To our knowledge, this is the first assessment of nurse-centered
ART within a context of a nationally coordinated program seeking
Table 4. Correctness of eligibility assessment and
completeness of patient record at intake and during follow-up
of patients started on antiretroviral treatment (n=1,076).
Indicator
a n (%)
Assessment at intake among patients initiating ART
(n=435)
Physical examination complete 422 (97.0)
Tuberculosis screening complete (four questions) 426 (97.9)
Reproductive health assessment complete (n=276)
b 232 (84.0)
All ART contraindications evaluated 430 (98.8)
WHO clinical staging documented 435 (100)
Functional status documented 426 (97.9)
Baseline CD4 count documented 434 (99.8)
Baseline weight documented 434 (99.8)
Baseline laboratory tests documented 406 (93.3)
Eligibility assessment
c
Ineligible patients started on ART (n=622) 0 (0)
Eligible patients not started on ART (n=451) 16 (3.5)
Assessment during follow-up
Side effect screening at every visit (n=386)
d 322 (83.4)
Adherence assessed at every visit (n=240)
d,e 214 (89.2)
CD4 count/weight available
f
At 6 mo (n=217) 193 (88.9)/200 (92.2)
At 12 mo (n=123) 104 (84.5)/111 (90.2)
At 18 mo (n=43) 31 (72.1)/28 (65.1)
At 24 mo (n=10) 10 (100.0)/6 (60.0)
an=435 unless stated otherwise.
bOnly for female patients (date of last menstrual periods, contraceptive use;
pregnancy and breastfeeding status); considered complete if all questions
adequately addressed.
cEligibility could not be determined for three patients since baseline WHO stage
or CD4 count not documented.
dOnly considering patients starting ART at least 1 mo prior to data collection.
eExcluding one site where data on adherence were recorded differently.
fWithin 3 mo of the time point.
doi:10.1371/journal.pmed.1000163.t004
Table 3. Demographic and clinical characteristics of patients enrolled into the pilot study.
Characteristic Pre-ART (n=641) ART (n=435) Total (n=1,076)
Female 433 (67.7%) 276 (63.4%) 710 (66.0)
Age (y) 37 (30–44) 39 (33–46) 38 (31–45)
WHO clinical stage
Stage I 462 (72.4%) 103 (23.7%) 565 (52.7%)
Stage II 127 (19.9%) 171 (39.3%) 298 (27.8%)
Stage III 47 (7.4%) 152 (34.9%) 199 (18.5%)
Stage IV 2 (0.3%) 9 (2.1%) 11 (1.0%)
Baseline weight (kg) 54 (49–59) 52 (46–58) 53 (46–58)
Baseline CD4 count (cells/ml) 643 (464–846) 184 (116-–231) 382 (194–694)
Time since enrolment (mo) 4.1 (0.6–11.7) 14.4 (7.7–22.2) 8.0 (1.7–16.7)
Time on ART (mo) — 8.3 (2.6–15.9) —
Data reported as either frequency (percent) or as median (IQR).
doi:10.1371/journal.pmed.1000163.t003
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cell count (right).
doi:10.1371/journal.pmed.1000163.g001
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doi:10.1371/journal.pmed.1000163.g002
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evaluation suggests that with adequate preparation and support
nurses can effectively prescribe first-line ART and monitor
noncomplex patients. Nurses participating in the initiative
achieved high compliance with national guidelines and excellent
patient outcomes. The experience demonstrates the feasibility and
suggests effectiveness of nurse-centered task shifting for decentral-
ized ART services without compromising the quality of care.
Our findings bear out positive reports from other African
countries. While Morris et al. [12] describe a task-shifting strategy
used in clinics in Lusaka, Zambia, Stringer and colleagues [13]
report robust treatment adherence and patient outcomes from a
large cohort at urban primary care sites in the city. The treatment
services relied primarily on nonphysician clinicians to provide
initial patient management with rotating physicians consulting
complex patients. Specialist HIV clinicians outside of Zambia
could be consulted as well via internet [12]. While confirming the
feasibility of involving nonphysician clinicians, the Zambian
program relied heavily on clinical officers, who have received
substantial medical training but are of limited availability in many
African countries. In addition, no formal assessment of the
performance of the nonphysician clinicians was reported and no
details were provided on the practical organization (training, task-
distribution), implementation, and supervision within the program.
In South Africa, an expanded role for nurses in AIDS care,
including nurse-initiated ART, was tried in order to enhance
service delivery in rural communities [14]. An assessment of
program data from Lusikisiki showed significantly increased
enrollment of patients on treatment through decentralized rural
services, whereas the hospital ART enrollment capacity was
rapidly exceeded. Furthermore, a comparison of 1-y outcome data
on retention, CD4 monitoring and response, and viral load
consistently showed outcomes for rural clinic patients to be
significantly better than patients treated at hospitals. No
assessment of nurses’ performance was reported, however, and
details of the step-by-step organization of nurse-initiated ART was
lacking.
That the task-shifting initiative in Rwanda was carried out
within a national framework with the explicit objective to evaluate
its safety and potential for policy development represents an
important addition to the existing literature. Our report provides a
detailed description of the structure and content of the
intervention as well as additional evidence that nurse-initiated
ART may be a viable strategy for expanding access to AIDS
treatment to rural populations. In combination with an indepen-
dent evaluation commissioned by the Ministry of Health in early
2008 [15], the present evaluation forms the basis of national plans
to adopt this task-shifting strategy for national-level ART scale-up.
Compared to a recent evaluation of the national ART program
in Rwanda during 2004–2005, our study found that patient
retention at the facility level was 89% at 12 mo of ART, close to
the national estimate of 87% for adult patients attending similar
size health centers in Rwanda, where care is generally provided by
physicians [16]. Whereas documented mortality at 12 mo was
slightly higher in our program (8.5% versus 5.7%), LTFU was
substantially lower (0.3% versus 3.2%). Comparable changes in
weight and CD4 cell count were also observed. Overall, key
patient outcomes from this task-shifting model were also
comparable to findings from other cohorts in sub-Saharan Africa.
For example, in a recent systematic review of ART programs in
sub-Saharan Africa, retention at 1 y after ART initiation was
estimated at 70% [11]. Similar mortality rates, stratified by
baseline CD4 count or WHO stage, were reported in large
programs in Zambia [13], Malawi [17], and numerous other
countries in the region [16,18].
The limitations of this study include the fact that data presented
are descriptive and no direct comparison of outcomes within this
nurse-centered model of care was made with those from
traditional physician-centered models, which makes it difficult to
ascertain if patients’ outcomes were as a result of the nurses’ role or
due to MDs’ intensive supervision. Furthermore, we should
exercise caution when interpreting the retention results given that
the median follow-up time for patients in this sample was 8.3 mo.
Although the sites selected were generally comparable to other
PHCs in Rwanda, the fact that neither the sites nor the patients
were randomly selected implies that our findings cannot
necessarily be generalized to other sites or even to other patients
at these particular sites. The criteria used to identify pilot sites
favored PHCs that offered relatively favorable conditions,
particularly with strong management and adequate staffing. Also,
we selected nurses with substantial clinical experience prior to the
pilot initiative. Finally, participation in a closely monitored pilot
project can itself increase commitment from both nurses and
physicians. Future sites will need to meet a minimum set of criteria
for safe and effective nurse-initiated ART delivery.
To avoid over-reliance on nursing skills for HIV care and
treatment, the tasks and responsibilities of nurses and physicians
will also need to be clear. As we task shift some clinical
responsibilities to nurses, we must also consider the modified role
of physicians, which will require provision of care for complex
patients while at the same time providing overall oversight of
patient management by the nurses. Not only provider roles but
Table 5. Model-estimated mean change in CD4 cell count and weight after initiation of ART, by baseline WHO stage (n=404).
Measures of clinical and Biological Status Between 0 to 6 mo Mean (95% CI) Between 6 to 24 mo Mean (95% CI)
Weight change (kg)
WHO Stage I 1.8 (0.6–3.0) 0.5 (23.8 to 4.7)
WHO Stage II 1.8 (1.0–2.6) 1.0 (21.3 to 3.3)
WHO Stage III/IV 4.4 (3.5–5.2) 1.8 (20.2 to 3.7)
CD4 cell count (cells/ml)
WHO Stage I 96.7 (69.4–124.1) 126.0 (29.6 to 261.5)
WHO Stage II 94.0 (76.1–111.7) 79.1 (14.2–144.0)
WHO Stage III/IV 128.0 (108.7–147.3) 128.9 (65.0–192.7)
Models also control for site, age, gender, and ART regimen (AZT-containing and/or NVP-containing). CD4 model also controls for baseline weight, dichotomized at the
gender-specific median. Excludes 30 patients who either died or were transferred prior to the 6-mo visit/measurement.
doi:10.1371/journal.pmed.1000163.t005
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periodically revised, and upgraded to meet evolving clinical
challenges. In particular, treatment failure will be an important
challenge in the future, as will provision of treatment and follow-
up to children. Both will require careful monitoring and an
appropriate mix of physician and nurse skills. To emphasize the
complementary nurse-physician skill mix necessary to provide high
quality patient care, it might be more appropriate to conceptualize
this approach as ‘‘task sharing’’ rather than task shifting. Specific
guidelines to scale-up the initiative should thus focus on defining
roles and responsibilities of the nurse-physician patient care team.
Additionally, this nurse-physician task shifting is best framed
within a whole context of task transfers for patient care, including
to community health workers, family members, and patients
themselves.
In addition, regulatory frameworks integrating task shifting
within national policy on human resources for health should be
established [19,20]. Given the severe shortage of human resources
for health, task shifting in isolation is not recommended but rather
as combined with wider investment in human resources and health
systems strengthening more generally [20]. High quality preservice
training with regular in-service updates, focusing not only on
theory but actual clinical practice, will be pivotal for the long-term
success of task shifting [20]; training curricula will need to be
tailored to different nursing and nonphysician practitioners
providing care in different African settings [21]. Adapted medical
records, tools, and protocols to assist nurses and other health
professionals to perform in this expanded AIDS care role will also
be necessary [21]. Further research on successful and cost-effective
implementation models, as well as studies on patient and health
care worker perspectives will also be of interest [5].
The potential benefit of this task-shifting model likely extends
beyond HIV patient care, as indicated by Chung and colleagues
[22]. Including time estimates for physician supervision and
consultation in complicated cases, Chung and colleagues estimate
that nurse-initiated ART for noncomplex cases saved approxi-
mately 45 min of physician time for every 1 h worked by a
prescribing nurse. If task shifting were applied nationally to the
future roll-out of ART in Rwanda, their simulation model
suggested a 76% reduction in the HIV care burden for physicians.
Physician time spared through ART task shifting could be used for
other patient care, mentoring, and quality improvement activities.
On this point, specific guidance and systems may be in order;
whereas the task of the nurses was clearly defined and evaluated in
this pilot initiative, the new roles that physicians could play was not
explored. On the other hand, the impact of this model on the
overall health system, and specifically on other activities where the
nurses would have been used, was not explored either.
Given the shortage of physicians in many African countries [8],
nurses have long played an important role in the management and
treatment of key diseases, such as tuberculosis and malaria,
typically with well-established task descriptions, clear referral
indications, and documented good results [5]. This report adds to
the evidence base that nurses can play a similarly effective role in
HIV care. It further advocates for decentralized HIV care and
treatment at the primary health clinic level [23]. If carefully
conceived and monitored, task shifting for HIV care offers a
promising strategy to address physician shortages in many
resource-limited countries and will likely have benefits across the
health sector.
Acknowledgments
We are grateful to the staff of the health centers and district hospitals
involved in this project. We are particularly grateful to all patients who
participated in this pilot program. We also acknowledge the valuable
contributions of Martin Ngabonziza and Bruno Ngirabatware in designing
and supporting the intervention. This program was part of and has
benefited from the successful scaling-up of the Rwandan National HIV
program, organized through the National AIDS Control Commission
(NACC) and the Treatment and Research AIDS Center – Center for
Infectious Disease Control (TRACplus-CIDC) and in collaboration with
various international partners.
Author Contributions
ICMJE criteria for authorship read and met: FS JVG DL IT MAW JP AB.
Agree with the manuscript’s results and conclusions: FS JVG DL IT MAW
JP AB. Designed the experiments/the study: FS JVG DL JP. Analyzed the
data: JVG DL MAW. Collected data/did experiments for the study: FS
JVG DL IT. Wrote the first draft of the paper: FS JVG. Contributed to the
writing of the paper: FS JVG DL IT MAW JP AB.
References
1. World Health Organization (2008) Towards universal access: scaling up priority
HIV/AIDS interventions in the healthsector:progress report. Geneva: World Health
Organization, Available: http://www.who.int/hiv/pub/towards_universal_access_
report_2008.pdf. Accessed 2 September 2008.
2. Van Damme W, Kober K, Laga M (2006) The real challenges for scaling up
ART in sub-Saharan Africa. AIDS Patient Care STDS 20: 653–656.
3. World Health Organization (2006) Taking stock: health worker shortages and
the response to AIDS. Geneva: World Health Organization, Available: http://
www.who.int/hiv/toronto2006/takingstockttr.pdf. Accessed 2 September 2008.
4. World Health Organization (2008) Task shifting: rational redistribution of task
among health workforce teams: global recommendations and guidelines.
Geneva: World Health Organization, Available: http://www.who.int/hiv/
healthsystems/TTR-TaskShifting.pdf. Accessed 2 September 2008.
5. Samb B, Celletti F, Holloway J, Van Damme W, De Cock KM, et al. (2007)
Rapid expansion of the health workforce in response to the HIV Epidemic.
N Engl J Med 357: 2510–2514.
6. Ministry of Health Rwanda (2005) Demographic and Health Survey 2005. Kigali:
Ministry of Health, Available: http://www.moh.gov.rw/press_release_dhs.htm.
Accessed 2 September 2008.
7. Treatment and Research AIDS Center (2007) Annual TRAC Report. Kigali:
Treatment and Research AIDS Center, Available: http://www.tracrwanda.org.
rw/reports_pdf/TRAC_RAPPORT_ANNUEL_2007.pdf.
8. Ministry of Health Rwanda (2006) Human resources for health: strategic plan
2006–2008. Kigali: Ministry of Health, Available: http://www.moh.gov.rw/
docs/Rwanda%20HRH%20strategic%20plan%20Final%20version-2010.pdf.
Accessed 2 September 2008.
9. World Health Organization (2006) Scaling-up antiretroviral therapy in resource-
limited settings: treatment guidelines for a public health approach: 2003 revision.
Geneva: World Health Organization, Available: http://www.who.int/hiv/pub/
guidelines/artadultguidelines.pdf. Accessed 2 September 2008.
10. World Health Organization (2007) Chronic HIV care with ARV therapy and
prevention. Geneva: World Health Organization, Available: http://www.who.
int/hiv/pub/imai/Crhonic_HIV_Care7.05.07.pdf. Accessed 2 September
2008.
11. Rosen S, Fox MP, Gill CJ (2007) Patient retention in antiretroviral therapy
programs in sub-Saharan Africa: a systematic review. PLoS Med 4: e298.
doi:10.1371/journal.pmed.0040298.
12. Morris MB, Tambatamba C, Chi BH, Mwango A, Chi HF, et al. (2009) Use of
task-shifting to rapidly scale-up HIV treatment services: experiences from
Lusaka, Zambia. BMC Health Serv Res 9: 1–9.
13. Stringer JSA, Zulu I, Levy J, Stringer EM, Mwango A, et al. (2006) Rapid scale-
up of antiretroviral therapy at primary care sites in Zambia: feasibility and early
outcomes. JAMA 296: 782–793.
14. Bedula M, Ford N, Hilderbrand K, Reuter H (2007) Implementing
antiretroviral therapy in rural communities: the Lusikisiki model of decentralized
HIV/AIDS care. J Infect Dis 196: S464–S468.
15. Nyamwasa D (2007) Evaluation des infirmiers prescripteurs de la multi the ´rapie
antiretroviral dans les centres de sante ´ de Kirambi, Kivumu, et Nyarusange.
Kigali: Rwanda Ministry of Health.
16. Lowrance DW, Ndamage F, Kayirangwa E, Ndagije F, Lo W, et al. (2009) Adult
clinical and immunologic outcomes of the national antiretroviral treatment
program in Rwanda during 2004–2005. J Acquir Immune Defic Syndr 52:
49–55.
17. Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, et al. (2006) Scaling
up of highly active antiretroviral therapy in a rural district of Malawi: an
effectiveness assessment. Lancet 367: 1330–1342.
Task Shifting for Nurse-Initiated HAART
PLoS Medicine | www.plosmedicine.org 9 October 2009 | Volume 6 | Issue 10 | e100016318. Braitstein P, Brinkhop MW, Dabis F, Schechter M, Boulle A, et al. (2006)
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy:
comparison between low-income countries. Lancet 367: 817–824.
19. Stilwell B, Wilson A, McCaffery J (2008) Non-physician clinicians in sub-
Saharan Africa. Lancet 371: 1578.
20. Philips M, Zachariah R, Venis S (2008) Task shifting for antiretroviral treatment
delivery in sub-Saharan Africa: not a panacea. Lancet 371: 682.
21. Mullan F, Frehywot S (2007) Non-physician clinicians in 47 sub-Saharan
African countries. Lancet 370: 2158–2163.
22. Chung J, O’Brian M, Price J, Shumbusho F (2008) Quantification of physician-
time saved in a task shifting pilot program in Rwanda. Proceedings of the XVII
International AIDS Conference; 3–8 August 2008; Mexico City, Mexico.
Available: http://www.aids2008.org/abstract.aspx?elementId=200720910.
23. World Health Organization (1978) Declaration of Alma-Ata. Geneva: World
Health Organization, Available: http://www.who.int/publications/almaata_
declaration_en.pdf. Accessed 2 September 2008.
Task Shifting for Nurse-Initiated HAART
PLoS Medicine | www.plosmedicine.org 10 October 2009 | Volume 6 | Issue 10 | e1000163Editors’ Summary
Background. Infection with the human immunodeficiency
virus (HIV) is a serious health problem in sub-Saharan Africa.
The virus attacks white blood cells that protect against
infection, most commonly a type of white blood cell called
CD4. When a person has been infected with HIV for a long
time, the number of CD4 cells they have goes down,
resulting in acquired immune deficiency syndrome (AIDS), in
which the person’s immune system no longer functions
effectively.
The World Health Organization (WHO) has divided the
disease into four stages as it progresses, according to
symptoms including weight loss and so-called opportunistic
infections. These are known as clinical stage I, II, III, or IV but
were revised and renamed 1, 2, 3, and 4 in September 2005.
HIV infection and AIDS cannot be cured but they can be
managed with antiretroviral treatment (ART). The WHO
currently recommends that ART is begun when the CD4
count falls below 350.
Rwanda is a country situated in the central Africa with a
population of around 9 million inhabitants; over 3% of the
rural population and 7% of the urban population are
infected with HIV. In 2007, the WHO estimated that
220,000 Rwandan children had lost one or both parents to
AIDS.
Why Was This Study Done? The WHO estimates that 9.7
million people with HIV in low- to middle-income countries
need ART but at the end of 2007, only 30% of these,
including in Rwanda, had access to treatment. In many low-
income countries a major factor in this is a lack of doctors.
Rwanda, for example, has one doctor per 50,000 inhabitants
and one nurse per 3,900 inhabitants.
This situation has led the WHO to recommend ‘‘task
shifting,’’ i.e., that the task of prescribing ART should be
shifted from doctors to nurses so that more patients can be
treated. This type of reorganization is well studied in high-
income countries, but the researchers wanted to help
develop a system for treating AIDS that would be effective
and timely in a predominantly rural, low-income setting such
as Rwanda.
What Did the Researchers Do and Find? In conjunction
with the Rwandan Ministry of Health, the researchers
developed and piloted a task-shifting program, in which
one nurse in each of three rural Rwandan primary health
centers (PHCs) was trained to examine HIV patients and
prescribe ART in simple cases. Nurses had to complete more
than 50 consultations observed by the doctor before being
permitted to consult patients independently. More complex
cases were referred to a doctor. The authors developed
standard checklists, instructions, and evaluation forms to
guide nurses and the doctors who supervised them once a
week.
The authors evaluated the pilot program by reviewing the
records of 1,076 patients who enrolled on it between
September 2005 and March 2008. They looked to see
whether the nurses had followed guidelines and monitored
the patients correctly. They also considered health outcomes
for the patients, such as their death rate, their body weight,
their CD4 cell count, and whether they maintained contact
with caregivers.
They found that by March 2008, 451 patients had been
eligible for ART. 435 received treatment and none of the
patients were prescribed ART when they should not have
been.Onlyoneprescriptiondidnotfollownationalguidelines.
At every visit, nurses were supposed to assess whether
patients were taking their drugs and to monitor side effects.
They did this and maintained records correctly for the vast
majority of the 435 patients who were prescribed ART. 390
patients (over 90%) of the 435 prescribed receiving ART
continued to take it and maintain contact with the pilot
PHC’s program. 29 patients died. Only one was lost to follow
up and the others transferred to another ART site. The
majority gained weight in the first six months and their CD4
cell counts rose. Outcomes, including death rate, were
similar to those treated on the (doctor-led) Rwandan
national ART program and other sub-Saharan African
national (doctor-led) programs.
What Do These Findings Mean? The study suggests that
nurses are able to prescribe ART safely and effectively in a
rural sub-Saharan setting, given sufficient training,
mentoring, and support. Nurse-led prescribing of ART
could mean that timely, appropriate treatment reaches
many more HIV patients. It would reduce the burden of
HIV care for doctors, freeing their time for other duties, and
the study is already being used by the Rwandan Ministry of
Health as a basis for plans to adopt a task-shifting strategy
for the national ART program.
The study does have some limitations. The pilot program
was funded and designed as a health project to deliver ART
in rural areas, rather than a research project to compare
nurse-led and doctor-led ART programs. There was no group
of equivalent patients treated by doctors rather than nurses
for direct comparison, although the authors did compare
outcomes with those achieved nationally for doctor-led ART.
The most promising sites, nurses, and patients were selected
for the pilot and careful monitoring may have been an
additional motivation for the nurses and doctors taking part.
Health professionals in a scaled-up program may not be as
committed as those in the pilot, who were carefully
monitored. In addition, the nature of the pilot, which lasted
for under three years and recruited new patients throughout,
meant that patients were followed up for relatively short
periods.
The authors also warn that they did not consider in this
study the changes task shifting will make to doctors’ roles
and the skills required of both doctors and nurses. They
recommend that task shifting should be implemented as
part of a wider investment in health systems, human
resources, training, adapted medical records, tools, and
protocols.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000163.
N PLoS Medicine includes a page collecting together its
recent articles on HIV infection and AIDS that includes
research articles, perspectives, editorials, and policy forums
N SciDev.net provides news, views, and information about
science, technology, and the developing world, including a
section specific to HIV/AIDs
N The World Health Organization (WHO) has published a
downloadable booklet ‘‘Task Shifting to Tackle Health
Worker Shortages’’
N The WHO offers information on HIV and AIDS (in Arabic,
Chinese, English, French, Russian, and Spanish) as well as
health information and fact sheets on individual countries,
including on Rwanda
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Sexually Transmitted Infections (STI) Surveillance gathers
and publishes data on the prevalence of HIV and AIDS in
individual countries, including on Rwanda
N AIDS.ORG provides information to help prevent HIV
infections and to improve the lives of those affected by
HIV and AIDS. Factsheets on many aspects of HIV and AIDS
are available. It is the official online publisher of AIDS
Treatment News
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